| 000 | 01066 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250514063218.0 | ||
| 264 | 0 | _c20030610 | |
| 008 | 200306s 0 0 eng d | ||
| 022 | _a1354-3784 | ||
| 024 | 7 |
_a10.1517/13543784.12.4.569 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRustin, Pierre | |
| 245 | 0 | 0 |
_aThe use of antioxidants in Friedreich's ataxia treatment. _h[electronic resource] |
| 260 |
_bExpert opinion on investigational drugs _cApr 2003 |
||
| 300 |
_a569-75 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntioxidants _xpharmacology |
| 650 | 0 | 4 |
_aClinical Trials as Topic _xstatistics & numerical data |
| 650 | 0 | 4 |
_aFriedreich Ataxia _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMyocardium _xmetabolism |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 773 | 0 |
_tExpert opinion on investigational drugs _gvol. 12 _gno. 4 _gp. 569-75 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/13543784.12.4.569 _zAvailable from publisher's website |
| 999 |
_c12458763 _d12458763 |
||